japanese flu drug 'clearly effective' in treating COVID-19, chinese medical officials say

japanese flu drug 'clearly effective' in treating COVID-19, chinese medical officials say

chinese medical officials say a japanese flu drug currently undergoing clinical trials is ‘clearly effective’ in treating COVID-19, reports forbes. developed by fujifilm toyama chemical, the drug — known as ‘favipiravir’ — has been tested on around 200 patients in wuhan and shenzen. these patients tested negative after a median of just four days, compared to 11 days in the control group.


‘it is very safe and clearly effective,’ said zhang xinmin, director of the science ministry’s china national center for biotechnology development — as reported by nikkei asian review. the same publication says that fujifilm toyama developed the drug in 2014 and it has been administered to patients in japan since february.


although the results appear promising for those showing minor symptoms, the guardian reports that ‘favipiravir’ does not seem to be as effective in more severe cases. fujifilm toyama’s stock price surged after the endorsement. however a chinese company — zhejiang hisun pharmaceutical — is preparing to put out a rival generic version of the drug.


read more about favipiravir in the report by forbes.

    have something to add? share your thoughts in our comments section below.
    all comments are reviewed for the purposes of moderation before publishing.

    comments policy
    LOG IN
    designboom's comment policy guidelines
    generally speaking, if we publish something, it's because we're genuinely interested in the subject. we hope you'll share this interest and if you know even more about it, please share! our goal in the discussion threads is to have good conversation and we prefer constructive opinions. we and our readers have fun with entertaining ones. designboom welcomes alerts about typos, incorrect names, and the like.
    the correction is at the discretion of the post editor and may not happen immediately.

    what if you disagree with what we or another commenter has to say?
    let's hear it! but please understand that offensive, inappropriate, or just plain annoying comments may be deleted or shortened.

    - please do not make racist, sexist, anti-semitic, homophobic or otherwise offensive comments.
    - please don't personally insult the writers or your fellow commenters.
    - please avoid using offensive words, replacing a few letters with asterisks is not a valid workaround.
    - please don't include your website or e-mail address in your comments for the purpose of self-promotion.
    - please respect jury verdicts and do not discuss offensively on the competition results
    (there is only one fist prize, and designboom usually asks renown professionals to help us to promote talent.
    in addition to the awarded designs, we do feel that almost all deserve our attention, that is why we publish
    the best 100-200 entries too.)

    a link is allowed in comments as long as they add value in the form of information, images, humor, etc. (links to the front page of your personal blog or website are not okay). unwelcome links (to commercial products or services of others, offensive material etc. ) will be redacted. and, ... yes, spam gets banned. no, we do not post fake comments.


    a diverse digital database that acts as a valuable guide in gaining insight and information about a product directly from the manufacturer, and serves as a rich reference point in developing a project or scheme.

    technology news

    keep up with our daily and weekly stories
    504,237 subscribers
    - see sample
    - see sample
    designboom magazine